Eli Lilly Launches Lawsuit Against Six Firms Over Unapproved GLP-1 Drugs

Eli Lilly filed a lawsuit targeting six pharmaceutical companies for allegedly marketing unapproved weight-loss drugs, positioning itself to maintain dominance in the competitive GLP-1 market alongside rival Novo Nordisk.